Managers / Q1 2020 · view latest →
CHASE INVESTMENT COUNSEL CORP
CIK 0000019475 · 350 OLD IVY WAY, SUITE 100, CHARLOTTESVILLE, VA, 22903-4897 · 4342939104
Summary
Chase Investment Counsel Corp reported $148M in U.S.-listed holdings across 67 positions for Q1 2020.
Its largest position, MSFT, represents 7.6% of the portfolio.
Compared with Q4 2019, the fund opened 20 new positions and exited 58.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 91.7% · $136M
- ADR · 5.5% · $8M
- PUBLIC · 1.4% · $2M
- Other · 0.8% · $1M
- ETP · 0.3% · $458,000
- Other · 0.2% · $369,000
Quarter-over-Quarter Changes full breakdown →
vs Q4 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| PEPPEPSICO INC | NEW | +35.0K | 35.0K | +$4M | $4M |
| ZTOZTO EXPRESS CAYMAN INC | NEW | +148.1K | 148.1K | +$4M | $4M |
| VRTXVERTEX PHARMACEUTICALS INC | NEW | +16.3K | 16.3K | +$4M | $4M |
| DOCUDOCUSIGN INC | NEW | +41.1K | 41.1K | +$4M | $4M |
| NEMNEWMONT CORP | NEW | +79.1K | 79.1K | +$4M | $4M |
| REGNREGENERON PHARMACEUTICALS | NEW | +7.2K | 7.2K | +$3M | $3M |
| DVADAVITA INC | NEW | +41.8K | 41.8K | +$3M | $3M |
| NVDANVIDIA CORP | NEW | +10.8K | 10.8K | +$3M | $3M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $381M | 149 | May 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $358M | 131 | Feb 5, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $338M | 131 | Nov 10, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $313M | 130 | Aug 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $273M | 122 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $311M | 134 | Feb 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $300M | 123 | Nov 5, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $282M | 122 | Aug 19, 2024 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2024 | $269M | 132 | May 2, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $226M | 118 | Feb 5, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $200M | 113 | Nov 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $198M | 92 | Jul 28, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $181M | 96 | May 4, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $163M | 91 | Jan 25, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $158M | 89 | Oct 31, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $185M | 99 | Jul 26, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $229M | 112 | Apr 21, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $250M | 115 | Feb 2, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $232M | 102 | Nov 4, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $242M | 104 | Jul 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $218M | 100 | May 6, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $227M | 101 | Feb 2, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $200M | 90 | Nov 3, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $198M | 96 | Aug 5, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $148M | 67 | May 8, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $197M | 105 | Feb 6, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $195M | 98 | Oct 29, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $197M | 95 | Aug 7, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $194M | 96 | May 3, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $168M | 91 | Feb 4, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.